CAD 0.99
(-5.71%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | -18.71 Million | -16.94 Million | -7.98 Million | -2.77 Million | -1.71 Million | -3.33 Million |
Net Income | -25.08 Million | -20.96 Million | -13.52 Million | -5.8 Million | -2.48 Million | -3.06 Million |
Depreciation & Amortization | 108.04 Thousand | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | 3.02 Million | 3.43 Million | 5.89 Million | 1.65 Million | 227.15 Thousand | 224.64 Thousand |
Change in working capital | -1.18 Million | 1.02 Million | -254.26 Thousand | 4611.00 | 349.48 Thousand | -138.83 Thousand |
Other non-cash items | 4.42 Million | -445.78 Thousand | -99.69 Thousand | 1.37 Million | 199.67 Thousand | -352.93 Thousand |
Investing Cash Flow | -22.68 Thousand | -200.9 Thousand | - | - | - | - |
Investments in PPE | -22.68 Thousand | -200.9 Thousand | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | 12.85 Million | 12.66 Million | 16.37 Million | 7.77 Million | 840.57 Thousand | 2.42 Million |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 11.6 Million | 9.65 Million | 14.6 Million | 6.7 Million | 888.7 Thousand | 2.12 Million |
Other Financing Activities | 1.25 Million | 3.01 Million | 1.77 Million | 1.06 Million | -48.12 Thousand | 297.43 Thousand |
Accounts receivables | -712.52 Thousand | 632.24 Thousand | -626.26 Thousand | -188.3 Thousand | 38.49 Thousand | 39.53 Thousand |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | -473.14 Thousand | 396.82 Thousand | 371.99 Thousand | 192.91 Thousand | 310.98 Thousand | -178.36 Thousand |
Cash at beginning of period | 8.94 Million | 13.42 Million | 5.02 Million | 26.13 Thousand | 896.05 Thousand | 1.81 Million |
Cash at end of period | 3.06 Million | 8.94 Million | 13.42 Million | 5.02 Million | 26.13 Thousand | 896.05 Thousand |
Capital Expenditure | -22.68 Thousand | -200.9 Thousand | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -5.87 Million | -4.48 Million | 8.39 Million | 4.99 Million | -869.92 Thousand | -914.68 Thousand |
Free Cash Flow | -18.73 Million | -17.14 Million | -7.98 Million | -2.77 Million | -1.71 Million | -3.33 Million |
Breakdown | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -10.78 Million | -1.68 Million | -3.1 Million | -9.5 Million | -20.96 Million | -3.32 Million |
Depreciation & Amortization | 27.94 Thousand | 27.94 Thousand | 26.07 Thousand | 26.07 Thousand | - | - |
Deferred income taxes | - | - | -971.66 Thousand | - | - | - |
Stock-based compensation | 1.79 Million | - | 1.23 Million | - | 3.43 Million | 825.49 Thousand |
Change in working capital | -537.33 Thousand | 284.18 Thousand | -1.02 Million | 89.95 Thousand | 1.02 Million | 972.7 Thousand |
Other non-cash items | 7.53 Million | -353.14 Thousand | 990.97 Thousand | -2.94 Million | -445.78 Thousand | -457.78 Thousand |
Investing Cash Flow | - | -15 Thousand | - | -7684.00 | -200.9 Thousand | -200.9 Thousand |
Investments in PPE | 4.00 | -15 Thousand | - | -7684.00 | -200.9 Thousand | -200.9 Thousand |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | 356.7 Thousand | 840.08 Thousand | 7.31 Million | 4.34 Million | 12.66 Million | 8.92 Million |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 356.7 Thousand | 840.08 Thousand | 7.31 Million | 4.11 Million | 9.65 Million | 9.65 Million |
Other Financing Activities | 356.7 Thousand | -28.01 Thousand | -284.12 Thousand | 229.36 Thousand | 3.01 Million | -726.85 Thousand |
Accounts receivables | -916.89 Thousand | 227.1 Thousand | 312.8 Thousand | -335.54 Thousand | 632.24 Thousand | 93.23 Thousand |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 379.56 Thousand | 57.07 Thousand | -1.33 Million | 425.49 Thousand | 396.82 Thousand | 879.46 Thousand |
Cash at beginning of period | 4.67 Million | 5.4 Million | 938.21 Thousand | 8.94 Million | 13.42 Million | 2.19 Million |
Cash at end of period | 3.06 Million | 4.67 Million | 5.4 Million | 938.21 Thousand | 8.94 Million | 8.94 Million |
Capital Expenditure | 4.00 | -15 Thousand | - | -7684.00 | -200.9 Thousand | -200.9 Thousand |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -1.6 Million | -731.89 Thousand | 4.46 Million | -8 Million | -4.48 Million | 6.74 Million |
Free Cash Flow | -1.96 Million | -1.57 Million | -2.85 Million | -12.34 Million | -17.14 Million | -2.18 Million |
DNAX
BZFD
TRTN-PC
CASH
9345
EPIGRAL